1. Inhibition of Lysyl Oxidases Impairs Migration and Angiogenic Properties of Tumor-Associated Pericytes
   Aline Lopes Ribeiro et al, 2017, Stem Cells International CrossRef
2. Tumor microenvironment determines response to a heat-activated thermosensitive liposome formulation of cisplatin in cervical carcinoma
   Yannan N. Dou et al, 2017, Journal of Controlled Release CrossRef
3. Comparing hydrazine-derived reactive groups as inhibitors of quinone-dependent amine oxidases
   Ashley A. Burke et al, 2017, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
4. Optical molecular imaging of lysyl oxidase activity – detection of active fibrogenesis in human lung tissue
   Tashfeen Aslam et al, 2015, Chem. Sci. CrossRef
5. Lysyl oxidase promotes epithelial-to-mesenchymal transition during paraquat-induced pulmonary fibrosis
   Jinfeng Wang et al, 2016, Mol. BioSyst. CrossRef
6. Lysyl Oxidase Gene G473A Polymorphism and Cigarette Smoking in Association with a High Risk of Lung and Colorectal Cancers in a North Chinese Population
   Guoli Wang et al, 2016, IJERPH CrossRef
7. Lysyl Oxidase and the Tumor Microenvironment
   Tong-Hong Wang et al, 2016, IJMS CrossRef
8. Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer
   Nobutake Tanaka et al, 2018, Sci Rep CrossRef
9. Lysyl Oxidase Genetic Variants Affect Gene Expression in Cervical Cancer
   Meimei Bu et al, 2014, DNA and Cell Biology CrossRef
10. Dynamic Matrisome: ECM Remodeling Factors Licensing Cancer Progression and Metastasis
    Arseniy E. Yuzhalin et al, 2018, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
11. Bifunctional Molecular Probes for Activity-Based Visualization of Quinone-Dependent Amine Oxidases
    Ashley A. Burke et al, 2018, Chem. Eur. J. CrossRef
12. ATP7A delivers copper to the lysyl oxidase family of enzymes and promotes tumorigenesis and metastasis
    Vinit Shanbhag et al, 2019, Proc Natl Acad Sci USA CrossRef
13. Epithelial-mesenchymal transition: a new target in anticancer drug discovery.
    Fabrizio Marcucci et al, 2016, Nat Rev Drug Discov CrossRef
14. Precancerous niche (PCN), a product of fibrosis with remodeling by incessant chronic inflammation
    Björn L.D.M. Brücher et al, 2019, 4open CrossRef
15. Quantification ofβ-aminopropionitrile, an inhibitor of lysyl oxidase activity, in plasma and tumor of mice by liquid chromatography tandem mass spectrometry
    Christelle Machon et al, 2014, Biomed. Chromatogr. CrossRef
16. Nuclear translocation of lysyl oxidase is promoted by interaction with transcription repressor p66β
    Irina A. Okkelman et al, 2014, Cell Tissue Res CrossRef
17. EMT in cervical cancer: its role in tumour progression and response to therapy.
    Rehana Qureshi et al, 2015, Cancer Lett CrossRef
18. LOX Expression and Functional Analysis in Astrocytomas and Impact of IDH1 Mutation
    Roseli da Silva et al, 2015, PLoS ONE CrossRef
19. Lysyl oxidase is associated with the epithelial–mesenchymal transition of gastric cancer cells in hypoxia
    Hiroaki Kasashima et al, 2016, Gastric Cancer CrossRef
20. Translational aspects in targeting the stromal tumour microenvironment: From bench to bedside
    R. Bhome et al, 2016 CrossRef
21. A simple method to induce hypoxia-induced vascular endothelial growth factor-A (VEGF-A) expression in T24 human bladder cancer cells
    Jonas Magno Santos Cesário et al, 2017, In Vitro Cell.Dev.Biol.-Animal CrossRef
22. Investigating the Mechanobiology of Cancer Cell–ECM Interaction Through Collagen-Based 3D Scaffolds
    Chiara Liverani et al, 2017, Cel. Mol. Bioeng. CrossRef
23. Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer
    Rebecca Kalikawe et al, 2019, Cancer Sci CrossRef
24. Novel 3‐aryl‐5‐substituted‐coumarin analogues: Synthesis and bioactivity profile
    Eleni Kavetsou et al, 2020, Drug Dev Res CrossRef
25. Divergent roles of lysyl oxidase family members in ornithine decarboxylase- and RAS-transformed mouse fibroblasts and human melanoma cells
    Mari Kielosto et al, 2018, Oncotarget CrossRef
26. Hypoxia-inducible factor-1α regulates epithelial-to-mesenchymal transition in paraquat-induced pulmonary fibrosis by activating lysyl oxidase
    Jian Lu et al, 2017, Exp Ther Med CrossRef
27. The prognostic value of the lysyl oxidase family in ovarian cancer.
    Miaomiao Ye et al, 2020, J Clin Lab Anal CrossRef
28. Roles of Lysyl Oxidase Family Members in the Tumor Microenvironment and Progression of Liver Cancer
    Hung-Yu Lin et al, 2020, IJMS CrossRef
29. Lysyl Oxidase (LOX) Transcriptionally Regulates SNAI2 Expression and TIMP4 Secretion in Human Cancers
    Myriem Boufraqech et al, 2016, Clin Cancer Res CrossRef
30. Tumor Hypoxia as a Barrier in Cancer Therapy: Why Levels Matter
    Tord Hompland et al, 2021, Cancers CrossRef
31. LOXL2 Inhibitors and Breast Cancer Progression
    Sandra Ferreira et al, 2021, Antioxidants CrossRef
32. Extracellular Matrices and Cancer-Associated Fibroblasts: Targets for Cancer Diagnosis and Therapy?
    Ismahane Belhabib et al, 2021, Cancers CrossRef
33. Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events?
    Giovanni Barillari et al, 2021, IJMS CrossRef
34. Lysyl Oxidase Family Enzymes and Their Role in Tumor Progression
    Tanya Liburkin-Dan et al, 2022, IJMS CrossRef
35. A Connexin-Based Biomarker Model Applicable for Prognosis and Immune Landscape Assessment in Lung Adenocarcinoma
    Junqing Qi et al, 2022, Journal of Oncology CrossRef
36. Role of the Hypoxic-Secretome in Seed and Soil Metastatic Preparation
    Cynthia Clemente-González et al, 2022, Cancers CrossRef
37. Expression of Amine Oxidase Proteins in Adrenal Cortical Neoplasm and Pheochromocytoma
    Eun Kyung Kim et al, 2023, Biomedicines CrossRef
38. Multiple Roles of LOXL2 in the Progression of Hepatocellular Carcinoma and Its Potential for Therapeutic Targeting
    Jelena Radić et al, 2023, IJMS CrossRef
39. The Inhibition of Vessel Co-Option as an Emerging Strategy for Cancer Therapy.
    Iván Carrera-Aguado et al, 2024, Int J Mol Sci CrossRef
40. A Lysyl Oxidase-Responsive Collagen Peptide Illuminates Collagen Remodeling in Wound Healing
    Paul Hiebert et al, 2024, Matrix Biology CrossRef
41. Apigenin 7-glucoside impedes hypoxia-induced malignant phenotypes of cervical cancer cells in a p16-dependent manner
    Yan Li et al, 2024 CrossRef
42. Evolving roles of lysyl oxidase family in tumorigenesis and cancer therapy.
    Miaomiao Ye et al, 2020, Pharmacol Ther CrossRef
43. Lysyl oxidase inhibitors in colorectal cancer progression
    Muxian Liu et al, 2025, Translational Oncology CrossRef